ALGISAP 2023: Pupilometric Evaluation of Patients Under Procedural Sedation With Propofol

Sponsor
Centre Hospitalier Universitaire de Nice (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05750485
Collaborator
(none)
50
1
3.8
13.1

Study Details

Study Description

Brief Summary

Procedural sedation involves the administration of sedative medications that allow patients to tolerate painful procedures. Procedural sedation has been formally recommended by experts from the French Society of Emergency Medicine (SFMU) since 2010 and procedural sedation using propofol in emergency departments has been recommended by the American College of Emergency Physicians in 2018.

Propofol monotherapy is now widely used in emergency medicine (EM) in France as part of procedural sedation for performing painful procedures, however propofol has no analgesic properties per se .

Pupilometry makes it possible to study the depth of analgesia by evaluating the body's nociceptive response via the ANS by studying the pupil diameter.

This technique would allow the evaluation of the analgesia level in patients sedated by PROPOFOL during the realization of painful procedures. Variations in pupil diameter during painful procedures under procedural sedation in an emergency department will be assesed in this study. Secondly, patients satisfaction following the procedure will also be evaluated by the use of the French version of the "ISAS-F", the Iowa Satisfaction with Anesthesia Scale.

Condition or Disease Intervention/Treatment Phase
  • Other: Pupilometric evaluation

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Pupilometric Evaluation of Nociception in Patients With Orthopedic Impairment Under Procedural Sedation With Propofol in the Context of the Use of the ALGISCAN Device in the Vital Emergency Department in Pasteur 2 Hospital, Nice France
Anticipated Study Start Date :
Mar 6, 2023
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Pupilometric evaluation under procedural sedation with propofol

Other: Pupilometric evaluation
Pupilometric evaluation under procedural sedation with propofol

Outcome Measures

Primary Outcome Measures

  1. pupil dilation reflex [up to 10 minutes]

    Amplitude of pupil dilation reflex (PRD, in % change in pupil diameter)

Secondary Outcome Measures

  1. Pupil diameter using the Algiscan device [up to 10 minutes]

    Pupil diameter using the Algiscan device during the painful procedure.

  2. Pupil diameter variation using the Algiscan [up to 10 minutes]

    Pupil diameter variation using the Algiscan device during the painful procedure.

  3. Heteroevaluation of the patient's maximal pain [up to 10 minutes]

    Heteroevaluation of the patient's maximal pain by the doctor, caregiver or nurse using the Algoplus scale (from 0 to 5) during the painful procedure.

  4. Patient's minimal Ramsay score [up to 10 minutes]

    Patient's minimal Ramsay score (from 0 to 6) during painful procedure

  5. Level of sedation [up to 10 minutes]

    Level of sedation ("qCON" consciousness index)as continuously measured by the Conox® device

  6. Patient satisfaction [up to 10 minutes]

    Patient satisfaction as evaluated by the study questionnaire When patients are fully awaked

  7. feasibility of the measurement [up to 10 minutes]

    Assessment of the feasibility of the measurement by the personnel who carried out the pupilometry measurement.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients

  • patient admitted at vital emergency room,

  • patient with an orthopedic trauma,

  • patient under procedural sedation with PROPOFOL.

Exclusion Criteria:
  • Patient's refusal of pupilometry measurement.

  • Pre-existing pupil abnormalities.

  • history of pathologies with dysautonomic impairment (advanced diabetes, systemic amyloidosis, multiple sclerosis, uncontrolled hypertension, ...).

  • Recent administration of Metoclopramide, Droperidol, Clonidine, Dexmedetomidine

  • Nitrous oxide prior to procedural sedation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nice University Hospital Nice France 06000

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nice

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier:
NCT05750485
Other Study ID Numbers:
  • 23Urgences01_Hamard
First Posted:
Mar 1, 2023
Last Update Posted:
Mar 1, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 1, 2023